España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Zenas BioPharma
ZBIO
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$7.85
0.07
0.90%
At close: -
$7.85
0.00
0.00%
After Hours: Jan 17, 4:00 PM EDT
Get Report
Comment
Zenas BioPharma (ZBIO) Forecast
News
Earnings
Zenas BioPharma (ZBIO) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Zenas BioPharma (NASDAQ:ZBIO) Stock
Zenas BioPharma Stock (NASDAQ: ZBIO)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, December 16, 2024
This Addus HomeCare Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Avi Kapoor
HC Wainwright & Co. Initiates Coverage On Zen...
Benzinga Newsdesk
Wednesday, December 11, 2024
Visa To Rally Over 20%? Here Are 10 Top Analyst Forecasts For Wednesday
Avi Kapoor
Morgan Stanley Maintains Overweight on Zenas ...
Benzinga Newsdesk
Tuesday, December 03, 2024
Guggenheim Reiterates Buy on Zenas BioPharma
Benzinga Newsdesk
Tuesday, November 12, 2024
Zenas BioPharma Completes Targeted Enrollment...
Benzinga Newsdesk
Friday, October 25, 2024
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
Tuesday, October 08, 2024
Citigroup Initiates Coverage On Zenas BioPhar...
Benzinga Newsdesk
Jefferies Initiates Coverage On Zenas BioPhar...
Benzinga Newsdesk
Morgan Stanley Initiates Coverage On Zenas Bi...
Benzinga Newsdesk
Guggenheim Initiates Coverage On Zenas BioPha...
Benzinga Newsdesk
Friday, September 13, 2024
Zenas BioPharma IPO Shares Open For Trade At ...
Benzinga Newsdesk
Trading Halt: Halt status updated at 10:35:00...
Benzinga Newsdesk
Reported Earlier, Zenas BioPharma Prices Upsi...
Benzinga Newsdesk
Thursday, September 12, 2024
Zenas Biopharma, Inc IPOs Tomorrow, Here's What You Need To Know
Benzinga Insights
